Literature DB >> 32402170

Teprotumumab for Active Thyroid Eye Disease.

Stephanie Kim1, Sophie Patzek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32402170     DOI： 10.1056/NEJMc2002754

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series.

Authors:  Matthew Chu; Jonathan Sung; Michael Song; Alice Song; Julia Song
Journal:  J Med Case Rep       Date:  2022-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.